|
Skybiotech Healthcare Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
25.69 Cr.
|
P/BV
|
2.94
|
Book Value (Rs.)
|
45.55
|
|
52 Week High/Low (Rs.)
|
239/127
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR |
| FaceValue | 10.00 |
| | |
| | |
| INCOME | |
| Revenue From Operations [Net] | 7.03 |
| Other Operating Revenues | 0.02 |
| Total Operating Revenues | 7.05 |
| | |
| Other Income | 0.38 |
| Total Revenue | 7.43 |
| | |
| EXPENSES | |
| Cost Of Materials Consumed | 3.67 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.06 |
| Employee Benefit Expenses | 1.96 |
| Finance Costs | 0.01 |
| Depreciation And Amortisation Expenses | 0.54 |
| Other Expenses | 3.72 |
| Total Expenses | 9.86 |
| | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -2.43 |
| | |
| Profit/Loss Before Tax | -2.43 |
| | |
| Tax Expenses-Continued Operations | |
| Current Tax | 0.02 |
| Deferred Tax | -0.07 |
| Total Tax Expenses | -0.06 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -2.37 |
| | |
| Profit/Loss From Continuing Operations | -2.37 |
| | |
| Profit/Loss For The Period | -2.37 |
| Consolidated Profit/Loss After MI And Associates | -2.37 |
| | |
| OTHER INFORMATION | |
| | |
| EARNINGS PER SHARE | |
| Basic EPS (Rs.) | -12.37 |
| Diluted EPS (Rs.) | -12.37 |
